TVRDNasdaq United States
Market cap
$23.266 M
$1.87 +1.08%
Close of 7 Aug 2026
Revenue
$7.14M
#3237 by revenue
Earnings
-$18.2M
Loss-making
Shares outstanding
9,381,344
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Tvardi Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.